SCHEMBL3086844

SCHEMBL3086844

c1ccc(N2c3ccccc3C(c3ccc(-n4c5ccccc5c5ccccc54)cc3)(c3ccc(-n4c5ccccc5c5ccccc54)cc3)c3ccccc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ ATM Q13315 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.36
▸ HDAC4 P56524 1/20 0.35
▸ MAPK8 P45983 2/20 0.35
▸ MAPK9 P45984 1/20 0.35
▸ PTPN1 P18031 2/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ GPR55 Q9Y2T6 1/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ THPO P40225 1/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ KDR P35968 1/20 0.32
▸ PGR P06401 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13143230 0.95 L3MBTL1 (0.50) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL21888241 0.92 KDM4E (0.45) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL2453894 0.92 L3MBTL1 (0.46) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL12333422 0.89 KDM4E (0.47) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL14296790 0.89 KDM4E (0.44) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL23056657 0.89 KDM4E (0.44) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL21889079 0.88 KDM4E (0.44) L3MBTL1KDM4EATMALDH1A1HDAC4
SCHEMBL20383392 0.88 KDM4E (0.41) L3MBTL1KDM4EATMMAPK8MAPK9
SCHEMBL21888172 0.87 KDM4E (0.40) L3MBTL1KDM4EATMHDAC4
SCHEMBL21889078 0.86 KDM4E (0.42) L3MBTL1KDM4EATMALDH1A1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029120-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-02 — — US disclosed
US-12029120-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-02 — — US disclosed
US-20230048761-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-16 — — US disclosed
US-20220380387-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-01 — — US disclosed
US-20220006026-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-01-06 — — US disclosed
US-10862048-B2 Organic electroluminescent device, thin luminous film, display apparatus, and lighting apparatus MERCK PATENT GMBH (DE) 2020-12-08 — — US disclosed
US-20180212157-A1 ORGANIC ELECTROLUMINESCENT DEVICE, THIN LUMINOUS FILM, DISPLAY APPARATUS, AND LIGHTING APPARATUS MERCK PERFORMANCE MATERIALS GERMANY GMBH (DE) 2018-07-26 — — US disclosed
US-20180212157-A1 ORGANIC ELECTROLUMINESCENT DEVICE, THIN LUMINOUS FILM, DISPLAY APPARATUS, AND LIGHTING APPARATUS MERCK PERFORMANCE MATERIALS GERMANY GMBH (DE) 2018-07-26 — — US disclosed
US-20160372683-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, DISPLAY DEVICE, ILLUMINATION DEVICE, AND LIGHT-EMITTING COMPOSITION Konica Minolta, Inc. (JP) 2016-12-22 — — US disclosed
US-20160372683-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, DISPLAY DEVICE, ILLUMINATION DEVICE, AND LIGHT-EMITTING COMPOSITION Konica Minolta, Inc. (JP) 2016-12-22 — — US disclosed
US-8384068-B2 Use of acridine derivatives as matrix materials and/or electron blockers in OLEDs BASF SE (DE) 2013-02-26 — — US disclosed
US-8384068-B2 Use of acridine derivatives as matrix materials and/or electron blockers in OLEDs BASF SE (DE) 2013-02-26 — — US disclosed
EP-2195868-B1 USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR AN ELECTRON BLOCKER IN OLEDS BASF SE (DE) 2013-01-02 — — EP disclosed
EP-2195868-B1 USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR AN ELECTRON BLOCKER IN OLEDS BASF SE (DE) 2013-01-02 — — EP disclosed
US-20100219406-A1 USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR ELECTRON BLOCKERS IN OLEDS BASF SE (DE) 2010-09-02 — — US disclosed
US-20100219406-A1 USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR ELECTRON BLOCKERS IN OLEDS BASF SE (DE) 2010-09-02 — — US disclosed
US-20100219406-A1 USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR ELECTRON BLOCKERS IN OLEDS BASF SE (DE) 2010-09-02 — — US disclosed
EP-2195868-A1 USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR AN ELECTRON BLOCKER IN OLEDS Basf Se (DE) 2010-06-16 — — EP disclosed
WO-2009047147-A1 USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR AN ELECTRON BLOCKER IN OLEDS BASF SE (DE) 2009-04-16 — — WO disclosed
WO-2009047147-A1 USE OF ACRIDINE DERIVATIVES AS MATRIX MATERIALS AND/OR AN ELECTRON BLOCKER IN OLEDS BASF SE (DE) 2009-04-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180212157-A1 ORGANIC ELECTROLUMINESCENT DEVICE, THIN LUMINOUS FILM, DISPLAY APPARATUS, AND LIGHTING APPARATUS LPO, L1CAM, EML4 L3MBTL1 132/4885KDM4E 2370/4885ATM 3229/4885
US-12029120-B2 Organic electroluminescence element and electronic device RPS10, H1-10, OR10J3 L3MBTL1 679/4885KDM4E 1340/4885ATM 3092/4885
US-20220380387-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE H1-2, H1-0, CCNE2 L3MBTL1 234/4885KDM4E 1204/4885ATM 854/4885
US-20230048761-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE CCNE2, EMC2, CHRM2 L3MBTL1 262/4885KDM4E 2553/4885ATM 1268/4885
US-10862048-B2 Organic electroluminescent device, thin luminous film, display apparatus, and lighting apparatus LPO, L1CAM, EML4 L3MBTL1 132/4885KDM4E 2370/4885ATM 3229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback